President Donald Trump announced a significant agreement with Pfizer on Tuesday (September 30) to lower drug prices in the United States. The deal involves Pfizer voluntarily reducing prices across its range of medications, though specific drugs and the extent of the price cuts were not disclosed. This initiative is part of President Trump's broader "Most Favored Nation" policy, which aims to ensure that the U.S. pays no more than the lowest prices charged in other wealthy countries.

According to a White House official, Pfizer will also launch a direct-to-consumer website called "TrumpRx," allowing Americans to purchase medications at discounted rates. Additionally, Pfizer plans to invest $70 billion in research, development, and domestic manufacturing.

The deal is part of Presiden

See Full Page